Patent · US Active

Assessing heart failure in patients with atrial fibrillation using GDF-15 and natriuretic peptides

US7955854B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Georg Hess · Mainz, DE
Andrea Horsch · Luzern, CH
Hendrik Huedig · Penzberg, DE
Dietmar Zdunek · Tutzing, DE

Key dates

Filing date	Nov 19, 2009
Grant date	Jun 7, 2011
Priority date	—
Expiry date	Nov 19, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/325
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed are a method, device, and test kit for diagnosing heart failure in a patient exhibiting atrial fibrillation. The method includes determining an amount of growth differentiation factor-15 (GDF -15) in a sample from the patient and comparing the amount of GDF-15 determined with a reference amount of GDF-15, wherein when the amount of GDF-15 determined is greater than the reference amount of GDF-15, a diagnosis of heart failure is indicated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.